Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RNFT1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNFT1 mRNA | CTD | PMID:22079256 | RNFT1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Rnft1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of RNFT1 mRNA | CTD | PMID:22206623 | RNFT1 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Rnft1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of RNFT1 mRNA | CTD | PMID:17555576 | RNFT1 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of RNFT1 mRNA | CTD | PMID:23019147 | RNFT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RNFT1 mRNA | CTD | PMID:17101203 | RNFT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rnft1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RNFT1 mRNA | CTD | PMID:33387578 | RNFT1 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of RNFT1 mRNA | CTD | PMID:32763439 | RNFT1 | Human | aflatoxin B1 | decreases expression | ISO | Rnft1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of RNFT1 mRNA | CTD | PMID:19770486 | RNFT1 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of RNFT1 mRNA | CTD | PMID:24449571 | RNFT1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of RNFT1 mRNA | CTD | PMID:33212167 | RNFT1 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of RNFT1 mRNA | CTD | PMID:22378314 | RNFT1 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RNFT1 mRNA | CTD | PMID:26238291 | RNFT1 | Human | bisphenol A | affects expression | ISO | Rnft1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of RNFT1 mRNA | CTD | PMID:25181051 | RNFT1 | Human | bisphenol A | decreases expression | ISO | Rnft1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RNFT1 mRNA | CTD | PMID:33221593 | RNFT1 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of RNFT1 mRNA | CTD | PMID:16002434 | RNFT1 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of RNFT1 mRNA | CTD | PMID:25979313 | RNFT1 | Human | dibutyl phthalate | increases expression | ISO | Rnft1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of RNFT1 mRNA | CTD | PMID:21266533 | RNFT1 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of RNFT1 mRNA | CTD | PMID:28302478 | RNFT1 | Human | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of RNFT1 mRNA | CTD | PMID:24236059 | RNFT1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | RNFT1 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of RNFT1 mRNA | CTD | PMID:29803840 | RNFT1 | Human | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of RNFT1 mRNA | CTD | PMID:25523186 | RNFT1 | Human | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of RNFT1 mRNA | CTD | PMID:25523186 | RNFT1 | Human | levonorgestrel | multiple interactions | EXP | | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA | CTD | PMID:19074003 | RNFT1 | Human | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of RNFT1 mRNA | CTD | PMID:26272509 | RNFT1 | Human | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNFT1 mRNA | CTD | PMID:27188386 | RNFT1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of RNFT1 mRNA | CTD | PMID:23649840 | RNFT1 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of RNFT1 mRNA | CTD | PMID:35430440 | RNFT1 | Human | paracetamol | increases expression | ISO | Rnft1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of RNFT1 mRNA | CTD | PMID:33387578 | RNFT1 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of RNFT1 mRNA | CTD | PMID:26272509 | RNFT1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNFT1 mRNA | CTD | PMID:27188386 | RNFT1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of RNFT1 mRNA | CTD | PMID:22079256 | RNFT1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNFT1 mRNA | CTD | PMID:22079256 | RNFT1 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of RNFT1 mRNA | CTD | PMID:21632981 | RNFT1 | Human | quinolin-8-ol | decreases expression | EXP | | 6480464 | Oxyquinoline results in decreased expression of RNFT1 mRNA | CTD | PMID:21632981 | RNFT1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | RNFT1 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of RNFT1 mRNA | CTD | PMID:31533062 | RNFT1 | Human | testosterone undecanoate | multiple interactions | EXP | | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA | CTD | PMID:19074003 | RNFT1 | Human | thioacetamide | increases expression | ISO | Rnft1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of RNFT1 mRNA | CTD | PMID:34492290 | RNFT1 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of RNFT1 mRNA | CTD | PMID:24935251 | RNFT1 | Human | tungsten | increases expression | ISO | Rnft1 (Mus musculus) | 6480464 | Tungsten results in increased expression of RNFT1 mRNA | CTD | PMID:30912803 | RNFT1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of RNFT1 gene | CTD | PMID:29154799 | RNFT1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of RNFT1 mRNA | CTD | PMID:25979313 | RNFT1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of RNFT1 mRNA | CTD | PMID:23179753 more ... | RNFT1 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNFT1 mRNA | CTD | PMID:27188386 | |